Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-high expression using real-world data.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743.
Annals of oncology : official journal of the European Society for Medical Oncology·2022